On June 26th, the Institute for Gene Therapies hosted its second Congressional Briefing focused on the promise of gene therapy, its...

Lauren Holder, Huntington’s Disease Patient Advocate and member of the Institute for Gene Therapy Patient Advocacy Advisory Council,...

Patients, researchers, and other key stakeholders are weighing in on the importance of the Medicaid VBPs for Patients Act, or the MVP Act...

Today, the Institute for Gene Therapies (IGT) sent a letter to Congress applauding Representatives Brett Guthrie (R-KY), Anna Eshoo...

By Nate Plasman This February, I had the opportunity to travel to Capitol Hill to participate in the Institute for Gene Therapy’s...

By IGT Chairman Erik Paulsen As more breakthrough gene therapies are developed and brought to market, a critical element in bringing...

On February 21, the Institute for Gene Therapies hosted a panel discussion on the science of gene therapy, its impact on patients and...

IGT Scientific, Academic, and Medical Council Chair Dr. Donna Christian-Christensen recently wrote an opinion piece for Inside Sources,...

By IGT Scientific, Academic & Medical Advisory Council Chair Donna M. Christensen Last week, during the Congressional Black Caucus...

Earlier this month the Institute for Gene Therapies submitted a comment letter to the Centers for Medicare and Medicaid Services (CMS) on...